Age and smoking intensity in non-small cell lung cancer patients with the anaplastic lymphoma kinase fusion gene

Age and smoking intensity in non-small cell lung cancer patients with the anaplastic lymphoma kinase fusion gene

Saved in:

Bibliographic Details
Main Authors:	Yosuke Maezawa, Manato Taguchi, Takeshi Kawakami, Toshihide Inui, Shinichiro Okauchi, Takeshi Numata, Toshihiro Shiozawa, Kunihiko Miyazaki, Ryota Nakamura, Kesato Iguchi, Takeo Endo, Tohru Sakamoto, Hiroaki Satoh, Nobuyuki Hizawa
Format:	Article
Language:	English
Published:	Termedia Publishing House 2025-03-01
Series:	Contemporary Oncology
Subjects:	anaplastic lymphoma kinase fusion gene alk non-small cell lung cancer driver gene gender age smoking
Online Access:	https://www.termedia.pl/Age-and-smoking-intensity-in-non-small-cell-lung-cancer-patients-with-the-anaplastic-lymphoma-kinase-fusion-gene,3,55707,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comprehensive study of anaplastic large cell lymphoma: clinicopathological features from Indonesia
by: Agnes Stephanie Harahap, et al.
Published: (2025-07-01)

An Isolated Cutaneous Relapse in a Known Case of Systemic ALK-Positive Anaplastic Large Cell Lymphoma: A Rare Case Report with Review of Literature
by: Monisha Shetty, et al.

Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma
by: Ahmed Salah, et al.
Published: (2025-05-01)

Corrigendum: Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma
by: Ahmed Salah, et al.
Published: (2025-06-01)

MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
by: E. V. Chernyshova, et al.
Published: (2017-01-01)

ALK-negative anaplastic large-cell lymphoma diagnosed on liver biopsy in a child presenting with nonresolving pyrexia
by: Aanchal Kakkar, et al.
Published: (2019-01-01)

Anaplastic lymphoma kinase-positive inflammatory myofibroblastic tumor of the breast: a case report and review of the literature
by: Yasutaka Kawakita, et al.
Published: (2023-09-01)

Primary bone ALK-positive anaplastic large cell lymphoma presented as a giant extraskeletal mass with coagulation necrosis
by: Shuji Nagata, et al.
Published: (2025-09-01)

PRIMARY PALATAL ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: RARITY TREATED SUCCESSFULLY WITH BRENTUXIMAB VEDOTIN
by: Müjgan Çözeli, et al.
Published: (2024-12-01)

Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)
by: YuE Vinogradova, et al.
Published: (2019-03-01)

Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
by: A. L. Pylev, et al.
Published: (2020-04-01)

PTPN2 Inhibition Disrupts Mitochondrial Renewal and Blocks TFRC‐Mediated Mitophagy to Exert Anti‐Tumor Activities in ALK‐Positive Anaplastic Large Cell Lymphoma
by: Wei‐Ting Wang, et al.
Published: (2025-08-01)

Pediatric Cutaneous Anaplastic Lymphoma Kinase-Positive Histiocytosis with <i>DCTN1::ALK</i> Fusion: A Case Report and Literature Search
by: Kristóf Levente Korpás, et al.
Published: (2025-04-01)

Integrative bioinformatic analysis identifies differentially expressed gene targets as potential biomarkers for anaplastic thyroid cancer
by: Angel Sebastian Treviño-Juarez, et al.
Published: (2025-05-01)

The Use of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer Treatment—Literature Review
by: Anita Gorzelak-Magiera, et al.
Published: (2024-10-01)

Spontaneous pneumothorax caused by an inflammatory myofibroblastic tumor-like lesion in a 14-year-old girl: a case report
by: Hisayuki Miyagi, et al.
Published: (2020-05-01)

A Rare Case of Anaplastic Lymphoma Kinase-negative Anaplastic Large Cell Lymphoma Presenting as Right Heart Failure
by: U. Harikishore, et al.
Published: (2025-01-01)

Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience
by: Claudia Parisi, et al.
Published: (2024-12-01)

Ensartinib in a primary pulmonary ALK-rearranged mesenchymal neoplasm harboring a novel HMBOX1::ALK fusion: a case report and literature review
by: Qi Liang, et al.
Published: (2025-05-01)

Case Report: A rare case of ALK-KIF5B gene fusion benefited from treatment with lorlatinib
by: Yuxi Luo, et al.
Published: (2025-08-01)

COMBINED CHEMOTHERAPY INCLUDING PROCARBAZINE (NATULAN) IN THE TREATMENT OF ANAPLASTIC OLIGODENDROGLIOMAS
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01)

New opportunities for preoperative diagnosis of anaplastic thyroid cancer
by: S. A. Lukyanov, et al.
Published: (2021-04-01)

Prognostic Factors for Patients with Small-Cell Lung Cancer Treated with Chemoimmunotherapy: A Retrospective Multicenter Study
by: Takashi Hatori, et al.
Published: (2024-10-01)

Successful treatment based on molecular biological assessment of invasive anaplastic lymphoma kinase-positive inflammatory myofibroblastic tumor of the lung
by: Hironosuke Watanabe, et al.
Published: (2019-07-01)

Regressed Papillary Thyroid Carcinoma with Anaplastic Transformation into Lymph Node Metastasis: Case Report with Review of the Literature
by: Bozidar Kovacevic, et al.
Published: (2025-02-01)

Ectopic Solitary Cortical Anaplastic Ependymoma in a Child: A Rare Entity with Short Illustrative Review
by: Sachin Guthe, et al.
Published: (2017-11-01)

Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer
by: Peng Song, et al.
Published: (2020-05-01)

Successful treatment of post chemotherapy esophageal cicatricial atresia in a pediatric patient with anaplastic large cell lymphoma through minimally invasive esophagectomy: a case report
by: Yuto Hozaka, et al.
Published: (2021-02-01)

Structural Analysis of the AlkB Family in Poultry
by: Yuling Niu, et al.
Published: (2025-07-01)

Targeted therapy of anaplastic thyroid cancer
by: P. A. Nikiforovich, et al.
Published: (2023-03-01)

Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
by: Haruhiko Yamazaki, et al.
Published: (2023-03-01)

Case Report: Remarkable and sustained remission of an anaplastic thyroid carcinoma patient to the combined treatment of multimodal radiotherapy, anlotinib and toripalimab
by: Yurou Xing, et al.
Published: (2025-05-01)

Anaplastic (undifferentiated) carcinoma of pancreas, an uncommon variant: Diagnosed on endoscopic-guided fine needle aspiration
by: Md Ali Osama, et al.
Published: (2023-07-01)

Anaplastic thyroid cancer: current capabilities of an oncologist
by: A. L. Pylev, et al.
Published: (2023-06-01)

Correction: Case Report: Remarkable and sustained remission of an anaplastic thyroid carcinoma patient to the combined treatment of multimodal radiotherapy, anlotinib and toripalimab
by: Yurou Xing, et al.
Published: (2025-07-01)

Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma
by: Haruhiko Yamazaki, et al.
Published: (2023-02-01)

Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas
by: Xing Liu, et al.
Published: (2018-09-01)

An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature Review
by: Shu-Cheng Wu, et al.
Published: (2024-01-01)

Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada
by: Lara Chayab, et al.
Published: (2024-12-01)

Modern treatment of ALK-positive non-small cell lung cancer
by: D. A. Kharagezov, et al.
Published: (2022-06-01)